Assistant Professor of Biomedical Engineering Adam Gormley and doctoral student Matthew Tamasi are developing biomedical technology that aims to destroy tumors using polymers that are so advanced they can be made very small and sent into the bloodstream to target cancer. Watch the report on News 12 New Jersey.
Recent Posts
- Founding partner Microsoft to bring new Discovery AI technology to NJ AI Hub.
- In Once-Redlined City Neighborhoods, Ambulances Still Lag Behind.
- How Alcohol Ads in Your Feed May Lead to Alcohol in Your Glass.
- Launch of NJIT’s B.S. in Enterprise AI Cultivates Next-Generation Tech Talent.
- Landmark Data from Rutgers Cancer Institute and RWJBarnabas Health Show Long-term Complete Responses of T Cell Therapies for HPV-Related Cancers.
Categories
- Community (2,401)
- Covid (993)
- CTO Events (6)
- News (3,039)
- Pilots (21)